PER-082-03已完成未知
RANDOMIZED PHASE II ASSAY OF CHEMOTHERAPY WITH METOTREXATE IN HIGH DOSES ONLY OR ASSOCIATED WITH CITARABINE IN HIGH DOSE, FOLLOWED BY RADIOTHERAPY ADEQUATE TO AGE AND RESPONSE FOR IMMUNOCOMPROMISED PATIENTS WITH RECENT DIAGNOSIS OF PRIMARY LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM.
INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP,0 个研究点目标入组 0 人开始时间: 2004年1月22日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Histological or cytological diagnosis of non-Hodgkins liymphoma.
- •Diagnostic sample obtained by stereotactic or surgical biopsy, CSF cytology examination or vitrectomy.
- •Disease exciusively localized into the central nervous system, cranial nerves or eyes.
- •Untreated patients (patients treated with steroids alone are eligibie).
- •At least one measurable lesion.
- •Age 18-75 years.
- •ECOG performance status < 3
排除标准
- •Not contemplated
研究者
相似试验
进行中（未招募）
不适用
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE, ALONE OR ASSOCIATED WITH HIGHDOSE CYTARABINE, FOLLOWED BY RESPONSE- AND AGE-TAILORED RADIOTHERAPY FOR IMMUNOCOMPETENT PATIENTS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAEUCTR2005-001055-38-ITINTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP IELSG80
进行中（未招募）
1 期
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE AND HIGH-DOSE CYTARABINE WITH OR WITHOUT THIOTEPA, AND WITH OR WITHOUT RITUXIMAB, FOLLOWED BY BRAIN IRRADIATION vs. HIGH-DOSE CHEMOTHERAPY SUPPORTED BY AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR IMMUNOCOMPETENT PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA - IELSGEUCTR2009-012432-32-DEniversity Medical Center Freiburg Dept. Klinikum Stuttgart, Stuttgart Cancer Center200
已完成
不适用
A Phase II Randomised Study of the Addition of Methotrexate 0.05 mg/kg 12 hourly for 8 doses to the Current Immunosuppressant Regimen for the Prevention of Liver Allograft Rejection.ISRCTN58758525Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)60
已完成
不适用
Phase II study of second-line chemotherapy using modified FOLFOX6 in patients with advanced/ recurrent colorectal cancer (OGSG 0505)Patients with unresectable or metastatic colon cancer registant to fluorouracil treatmentJPRN-UMIN000000841OGSG50
进行中（未招募）
不适用
Randomized fase II study using chemiotherapy with metformine in patients affected by pancreas metastatic cancer. - NDpancreas metastatic tumorMedDRA version: 9.1Level: HLTClassification code 10033632EUCTR2010-020979-23-ITFONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR